– USA, Cambridge, MA – Caldera Pharmaceuticals, a provider of services to the pharmaceutical and environmental monitoring industries, today announced the appointment of Tim Tyson to its Board of Directors.
“We are honored to have Tim join our Board. His leadership, his business experience and his wealth of knowledge of the pharmaceutical industry add a great deal to our team. I look forward to working with him, and gaining his counsel.” said CEO, Gary Altman.
About Timothy C. Tyson
Tim Tyson brings over 30 years of experience and is an internationally recognized leader in the pharmaceutical industry. He is currently the Chairman of Aptuit, a contract research organization providing services to the pharmaceutical industry. His previous leadership positions include his tenure as CEO of Aptuit and CEO of Valeant Pharmaceuticals. In addition, Mr. Tyson has held senior executive positions at GlaxoSmithKline and at Bristol-Myers.
Mr. Tyson is a United States Military Academy graduate and holds a Masterelements’ rapid, simultaneous detection and quantification of Public Administration and an MBA from Jacksonville State University.
About Caldera Pharmaceuticals and XRpro®
XRpro® has focused on its core competency to develop analytical tools that rely on elements’ rapid, simultaneous detection and quantification. Using X-ray fluorescence the company has developed assays for drug discovery, and for the real-time analysis of industrial effluents.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
